Fox Chase Cancer Center Endowed Chairs

Endowed Chairs Endowed Chairs Home Gloria and Edmund M. Dunn Chair in Thoracic Surgical Oncology Marvin S. Greenberg, MD Chair in Pancreatic Cancer Surgery G. Willing "Wing" Pepper Chair in Cancer Research Stanley P. Reimann Chair in Oncology Research Jack Schulz Chair in Basic Science Timothy R. Talbot Jr. Chair in Cancer Research Carol and Kenneth Weg Chair in Human Genetics Robert C. Young MD Chair in Cancer Research G. Morris Dorrance Jr. Chair Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology Gerald E. Hanks Chair in Radiation Oncology Alfred G. Knudson Jr. Chair in Basic Science Donald E. and Shirley C. Morel, Stanley and Stella Bayster Chair in Molecular Imaging Audrey Weg Schaus and Geoffrey Alan Weg Chair in Medical Science H.O. West and J.R. Wike Chair in Cancer Research William Wikoff Smith Chair in Cancer Research Chairholders Jeff Boyd, PhD Jonathan Chernoff, MD, PhD Mary B. Daly, MD, PhD, FACP Eric M. Horwitz, MD John P Hoffman, MD, FACS Beatrice Mintz, PhD Walter J Scott, MD, FACS Joseph R. Testa, PhD Robert G. Uzzo, MD, FACS

Marvin S. Greenberg, MD Chair in Pancreatic Cancer Surgery

Established in 2008 by Concetta Greenberg in honor of her late husband Marvin S. Greenberg, MD, this chair was established to support a leader in the field of pancreatic cancer surgery who has demonstrated clinical leadership and who represents the highest standards of excellence.

John P. Hoffman, MD, FACS

Surgical Oncology
Chief, Pancreaticobiliary Service
John Hoffman is the Division Chief of Pancreaticobiliary Surgery at Fox Chase Cancer Center. Coming from a general surgical background, he joined Fox Chase in 1986 with a desire to focus his surgical career on the treatment and advancement of treatment for cancer.

Dr. Hoffman specializes in treating cancers of the upper abdomen, including: liver, pancreatic, gastrointestinal, and breast cancers. Over the last 20 years, much of his time has been spent specifically on the development of new care and treatment methods for pancreatic cancer.

When he entered the field of surgical oncology in the mid-1970s, the dominant theory was that pancreatic cancers were not treatable. Now, more than thirty years later, Dr. Hoffman has seen and developed many advances in treatment options, including new drug therapies and advancements in surgical resections.

In a clinical setting, Dr. Hoffman and his team continue to test the efficacy of new drugs and treatment plans to improve the care of cancer patients at Fox Chase. In 2008, Dr. Hoffman became the first recipient of the Marvin S. Greenberg, MD Chair in Pancreatic Cancer Surgery, recognizing his distinct contributions to the evolution of pancreatic cancer medicine. He is also consistently named as one of Philadelphia Magazine's "Top Docs".